The cancer drug that changed everything: why Rituximab is still a...

добавлена новая статья Health

2026-04-15 11:54:46 -

The cancer drug that changed everything: why Rituximab is still a blockbuster after 25 years

First approved in 1997, Rituximab (Rituxan) was the first monoclonal antibody for cancer. It targets CD20 on B-cells, killing lymphoma cells while sparing healthy tissue. The rituximab market report by MRFR shows that non-Hodgkin lymphoma (NHL) is the largest indication, but chronic lymphocytic leukemia (CLL) is the fastest‑growing. The market is $34.52 billion and will hit $52.37...

0 Комментарии 0 Поделились 3 Просмотры 0 предпросмотр